CTRI/2020/09/027811招募中4 期
Intra lesional Vasopressin administration during Hysteroscopic Myomectomy: A randomized clinical trial.
Dr SMurali0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with Type0 ,1 and 2 myoma (Submucous myoma) who are scheduled to undergo hysteroscopic myomectomy
排除标准
- •1. Myoma > 5cm size
- •2. Acute PID
- •3. Use of preoperative GnRH agonists
- •4. Endometrial premalignant or malignant pathologies
- •5. Women with cardiopulmonary diseases, bleeding diathesis and renal disease.
- •6. Patients with multiple submucous myoma.
- •7. Hypertension.
研究者
相似试验
已完成
不适用
Effectiveness of Vasopressin During laparoscopic HysterectomyMyoma uteri, adenomyosisJPRN-UMIN000020396Takanohara Central Hospital80
已完成
不适用
The effect of Vasopressin on decreasing time of surgeryOvarian Endometrioma.Endometriosis of ovaryIRCT2013012512262N1Tehran University of Medical Science,14
招募中
不适用
The impact of using vasopressin at the time of removal of ovarian endometriosis cyst on a woman's egg count and endometriosis-related quality of life.EndometriosisACTRN12620001327976Sydney Women's Endosurgery Centre40
已完成
3 期
Evaluation the effect of vasopressin in ovarian endometriosis surgeryIRCT20200925048836N1Shiraz University of Medical Sciences80
已完成
3 期
Sub-endometrial injection of vasopressin for invasive placentapregnancy with placenta accreta.O00.0Abdominal pregnancyIRCT20191102045310N1Tehran University of Medical Sciences60